BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22531527)

  • 21. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
    Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
    Kumar A; Vanderplas A; LaCasce AS; Rodriguez MA; Crosby AL; Lepisto E; Czuczman MS; Nademanee A; Niland J; Gordon LI; Millenson M; Zelenetz AD; Friedberg JW; Abel GA
    Cancer; 2012 Jun; 118(11):2944-51. PubMed ID: 22006274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
    Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-cell lymphoma presenting as acute pancreatitis.
    Federico E; Falconi M; Zuodar G; Falconieri G; Puglisi F
    Pancreatology; 2011; 11(6):553-6. PubMed ID: 22205036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
    Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM
    Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of gastric stenosis due to primary gastric malignant lymphoma during administration of R-CHOP].
    Tamai Y; Murakami E; Nakamori Y; Mizutani M; Sekine T
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1371-3. PubMed ID: 21829084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary bone marrow diffuse large B cell lymphoma: a case series and review.
    Chang H; Hung YS; Lin TL; Wang PN; Kuo MC; Tang TC; Wu JH; Dunn P; Shih LY
    Ann Hematol; 2011 Jul; 90(7):791-6. PubMed ID: 21181164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
    Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK;
    Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary renal non-Hodgkin lymphoma: an unusual diagnosis for a renal mass.
    Belbaraka R; Elyoubi MB; Boutayeb S; Errihani H
    Indian J Cancer; 2011; 48(2):255-6. PubMed ID: 21768678
    [No Abstract]   [Full Text] [Related]  

  • 33. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
    Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
    Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
    Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP.
    Ribera JM; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Navarro JT; Feliu E
    Br J Haematol; 2012 Jun; 157(5):637-9. PubMed ID: 22313456
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.
    Kim KM; Yoon DH; Lee SG; Lim SN; Sug LJ; Huh J; Suh C
    J Korean Med Sci; 2009 Jun; 24(3):525-8. PubMed ID: 19543522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary non-Hodgkin lymphoma of the liver: case report and review of the literature].
    Nasr Ben Ammar C; Chaari N; Kochbati L; Besbes M; Maalej M
    Cancer Radiother; 2006 Dec; 10(8):595-601. PubMed ID: 17137818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
    Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
    Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
    Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
    Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.